These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19838147)

  • 1. Biodegradable stents and non-biodegradable stents.
    Garg S; Serruys P
    Minerva Cardioangiol; 2009 Oct; 57(5):537-65. PubMed ID: 19838147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term patient benefit with biodegradable polymer biolimus eluting stent.
    Corti R
    Minerva Cardioangiol; 2012 Dec; 60(6):629-36. PubMed ID: 23147439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary stents: looking forward.
    Garg S; Serruys PW
    J Am Coll Cardiol; 2010 Aug; 56(10 Suppl):S43-78. PubMed ID: 20797503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
    Waksman R; Pakala R
    EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New DES: a new step forward?
    Ko BS; Meredith IT
    Minerva Cardioangiol; 2012 Feb; 60(1):41-56. PubMed ID: 22322573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing vessel healing following drug eluting stent implantation with biodegradable polymer DES.
    Cerrato E; Echavarría-Pinto M; Tandjung K; Macaya C; Escaned J
    Minerva Cardioangiol; 2014 Oct; 62(5):407-20. PubMed ID: 25295492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.
    Chen SL; Ye F; Zhang JJ; Zou JJ; Qian XS; Li F; Yang S; Ge Z; Shan SJ; Li XB; Xu T; Kan J; Lin L; Han YL
    Cardiovasc Ther; 2013 Aug; 31(4):193-200. PubMed ID: 22954234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Absorbable coronary stents. New promising technology].
    Erbel R; Böse D; Haude M; Kordish I; Churzidze S; Malyar N; Konorza T; Sack S
    Herz; 2007 Jun; 32(4):308-19. PubMed ID: 17607538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials.
    Stefanini GG; Byrne RA; Serruys PW; de Waha A; Meier B; Massberg S; Jüni P; Schömig A; Windecker S; Kastrati A
    Eur Heart J; 2012 May; 33(10):1214-22. PubMed ID: 22447805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary drug-eluting stents: from design optimization to newer strategies.
    Sun D; Zheng Y; Yin T; Tang C; Yu Q; Wang G
    J Biomed Mater Res A; 2014 May; 102(5):1625-40. PubMed ID: 23703913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New generation coronary stent technology--is the future biodegradable?
    Sammel AM; Chen D; Jepson N
    Heart Lung Circ; 2013 Jul; 22(7):495-506. PubMed ID: 23548335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fully biodegradable coronary stents : progress to date.
    Ramcharitar S; Serruys PW
    Am J Cardiovasc Drugs; 2008; 8(5):305-14. PubMed ID: 18828642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of drug-eluting stents.
    Kukreja N; Onuma Y; Daemen J; Serruys PW
    Pharmacol Res; 2008 Mar; 57(3):171-80. PubMed ID: 18339557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of stent strut design in metallic stents and biodegradable scaffolds.
    Foin N; Lee RD; Torii R; Guitierrez-Chico JL; Mattesini A; Nijjer S; Sen S; Petraco R; Davies JE; Di Mario C; Joner M; Virmani R; Wong P
    Int J Cardiol; 2014 Dec; 177(3):800-8. PubMed ID: 25449502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
    Buszman P; Milewski K; Zurakowski A; Pajak J; Liszka Ł; Buszman P; Musioł E; AbuSamra M; Trznadel S; Kałuza G
    Kardiol Pol; 2010 May; 68(5):503-9. PubMed ID: 20491008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational Bench Testing to Evaluate the Short-Term Mechanical Performance of a Polymeric Stent.
    Bobel AC; Petisco S; Sarasua JR; Wang W; McHugh PE
    Cardiovasc Eng Technol; 2015 Dec; 6(4):519-32. PubMed ID: 26577483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year clinical outcome of a randomized trial of polymer-free paclitaxel-eluting stents versus biodegradable polymer-based rapamycin-eluting stents in patients with coronary heart disease.
    Zhang L; Yuan J; Liu G; Zhong JP; Yin YH; She Q; Su L; Ling ZY; Chen YQ
    J Interv Cardiol; 2012 Dec; 25(6):604-10. PubMed ID: 22384973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodegradable versus durable polymer drug eluting stents in coronary artery disease: insights from a meta-analysis of 5,834 patients.
    Lupi A; Rognoni A; Secco GG; Lazzero M; Nardi F; Fattori R; Bongo AS; Agostoni P; Sheiban I
    Eur J Prev Cardiol; 2014 Apr; 21(4):411-24. PubMed ID: 23152364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.